Abbotts Trading Volume Surges 157% to $33.49 Billion Ranking 25th in Market Despite 8.52% Stock Decline

On July 17, 2025, Abbott's trading volume reached $33.49 billion, marking a 157.21% increase from the previous day, placing it 25th in the day's market rankings. However, the stock price of Abbott (ABT) fell by 8.52%.

Abbott reported a 7.4% increase in second-quarter sales on a reported basis, with organic sales growth of 6.9% or 7.5% when excluding COVID-19 testing-related sales. The company's revenue for the quarter was $11.42 billion, surpassing analysts' expectations of $11.07 billion. This growth was driven by a 12% increase in device sales, reflecting strong performance across its product portfolio.

For the fiscal year 2025, Abbott projects organic sales growth of 7.5% to 8.0%, excluding COVID-19 testing-related sales, and full-year adjusted earnings per share (EPS) in the range of $5.10 to $5.20. The company's adjusted EPS for the second quarter was $1.26, beating the consensus estimate by 0.8%.

Despite the strong financial performance, Abbott's stock price declined in pre-market trading. This drop can be attributed to investor concerns over the company's future growth prospects and potential challenges in sustaining the current momentum. The market reaction highlights the importance of consistent performance and strategic initiatives in maintaining investor confidence.